MR. DOUGLAS ROBERT FLETCHER MD NPI 1740236090

NPI Details

MR. Douglas Robert Fletcher, MD is a pulmonary disease internal medicine in Middletown, NY with 40 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. MR. Douglas Robert Fletcher, MD NPI is 1740236090. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

111 MALTESE DR
MIDDLETOWN, NY
ZIP 10940
Phone: (845) 342-4774
Fax: (845) 818-7555

The NPI 1740236090 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Ct scan of chest without contrast (HCPCS:71250)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• X-ray of chest, 2 views (HCPCS:71046)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Sleep study in sleep lab with continuous airway pressure (6 years or older) (HCPCS:95811)

The enumeration date for this NPI number is 5/26/2006 and was last updated on 2/27/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.